Depression and Mania Induce Pro-inflammatory Activation of Macrophages Following Application of Serum from Individuals with Bipolar Disorder
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objective: Evidence has suggested that immune imbalance is involved with bipolar disorder (BD); however, its precise mechanism is poorly understood. This study investigated whether biochemical changes in the serum from BD patients could modulate the phenotype of cultured macrophages. Methods: Eighteen subjects with BD and five healthy individuals were included in this study. The human monocyte cell line U-937 was activated with phorbol 12-myristate 13-acetate (PMA) and polarization was induced with RPMI-1640 media supplemented with 10% serum from each patient for 24 hours. Gene expression of selected M1 and M2 markers was assessed by quantitative PCR. Results: Macrophages exposed to serum of manic and depressive BD patients displayed an increase of interleukin-1 (6.40±3.47 and 9.04±5.84 vs. 0.23±0.11; p＜0.05) and tumor necrosis factor- (2.23±0.91 and 2.03±0.45 vs. 0.62±0.24; p=0.002 and p=0.004, respectively) compared to euthymic group (there was no difference between euthymic and controls). In parallel, U-937 macrophages treated with serum of patients in acute episode displayed a down-regulation of CXCL9 (0.29±0.20 vs. 1.86±1.61; p=0.006) and CXCL10 expression (0.36±0.15 and 0.86±0.24 vs. 1.83±0.88; p＜0.000 and p=0.04) compared to the euthymia group. Conclusion: Our results are consistent with previous studies showing that changes in peripheral blood markers could modulate M1/M2 polarization in BD. The evidence of macrophages as source of inflammatory cytokines might be helpful to unravel how the mononuclear phagocyte system is involved in the etiology of BD.
Abstract
Objective: Evidence has suggested that immune imbalance is involved with bipolar disorder (BD); however, its precise mechanism is poorly understood. This study investigated whether biochemical changes in the serum from BD patients could modulate the phenotype of cultured macrophages. Methods: Eighteen subjects with BD and five healthy individuals were included in this study. The human monocyte cell line U-937 was activated with phorbol 12-myristate 13-acetate (PMA) and polarization was induced with RPMI-1640 media supplemented with 10% serum from each patient for 24 hours. Gene expression of selected M1 and M2 markers was assessed by quantitative PCR. Results: Macrophages exposed to serum of manic and depressive BD patients displayed an increase of interleukin-1 (6.40±3.47 and 9.04±5.84 vs. 0.23±0.11; p＜0.05) and tumor necrosis factor- (2.23±0.91 and 2.03±0.45 vs. 0.62±0.24; p=0.002 and p=0.004, respectively) compared to euthymic group (there was no difference between euthymic and controls). In parallel, U-937 macrophages treated with serum of patients in acute episode displayed a down-regulation of CXCL9 (0.29±0.20 vs. 1.86±1.61; p=0.006) and CXCL10 expression (0.36±0.15 and 0.86±0.24 vs. 1.83±0.88; p＜0.000 and p=0.04) compared to the euthymia group. Conclusion: Our results are consistent with previous studies showing that changes in peripheral blood markers could modulate M1/M2 polarization in BD. The evidence of macrophages as source of inflammatory cytokines might be helpful to unravel how the mononuclear phagocyte system is involved in the etiology of BD.
참고문헌 (27)
- Bai YM, "Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls", Bipolar Disord, 17, pp.269~277 (2015)[DOI]
- Dargel AA, "C-reactive protein alterations in bipolar disorder: a meta-analysis", J Clin Psychiatry, 76, pp.142~150 (2015)
- do Prado CH, "Reduced regulatory T cells are associated with higher levels of Th1", TH17 cytokines and activated MAPK in type 1 bipolar disorder, 2013, pp.38, 667~676
- Fiedorowicz JG, "Peripheral inflammation during abnormal mood states in bipolar I disorder", J Affect Disord, 187, pp.172~178 (2015)[DOI]
- Kauer-Sant'Anna M, "Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder", Int J Neuropsychopharmacol, 12, pp.447~458 (2009)[DOI]
- Knijff EM, "An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment", Bipolar Disord, 9, pp.743~753 (2007)[DOI]
- Ascoli BM, "The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets", Aust N Z J Psychiatry, 50, pp.618~630 (2016)[DOI]
- Kapczinski F, "Allostatic load in bipolar disorder: implications for pathophysiology and treatment", Neurosci Biobehav Rev, 32, pp.675~692 (2008)[DOI]
- Stertz L, "Damage-associated molecular patterns and immune activation in bipolar disorder", Acta Psychiatr Scand, 132, pp.211~217 (2015)[DOI]
- Vieta E, "The clinical implications of cognitive impairment and allostatic load in bipolar disorder", Eur Psychiatry, 28, pp.21~29 (2013)
- Nakagawa Y, "Diversity and plasticity of microglial cells in psychiatric and neurological disorders", Pharmacol Ther, 154, pp.21~35 (2015)[DOI]
- Beumer W, "The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes", J Leukoc Biol, 92, pp.959~975 (2012)[DOI]
- Reus GZ, "The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders", Neuroscience, 300, pp.141~154 (2015)[DOI]
- Smith RS, "A comprehensive macrophage-T-lymphocyte theory of schizophrenia", Med Hypotheses, 39, pp.248~257 (1992)[DOI]
- Williams JB, "A structured interview guide for the Hamilton Depression Rating Scale", Arch Gen Psychiatry, 45, pp.742~747 (1988)[DOI]
- Young RC, "A rating scale for mania: reliability, validity and sensitivity", Br J Psychiatry, 133, pp.429~435 (1978)[DOI]
- Becker M, "Integrated transcriptomics establish macrophage polarization signatures and have potential applications for clinical health and disease", Sci Rep, 5, pp.13351~ (2015)[DOI]
- Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method", Methods, 25, pp.402~408 (2001)[DOI]
- Munkholm K, "State-related alterations of gene expression in bipolar disorder: a systematic review", Bipolar Disord, 14, pp.684~696 (2012)[DOI]
- Munkholm K, "Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis", J Psychiatr Res, 47, pp.1119~1133 (2013)[DOI]
- O'Brien SM, "Cytokine profiles in bipolar affective disorder: focus on acutely ill patients", J Affect Disord, 90, pp.263~267 (2006)[DOI]
- Fries GR, "Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder", Int J Neuropsychopharmacol, 18 (2015)[DOI]
- Qi XR, "Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients", Psychoneuroendocrinology, 38, pp.863~870 (2013)[DOI]
- Sinclair D, "Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness", Sci Rep, 3, pp.3539~ (2013)[DOI]
- Dantzer R, "Salivary biomarkers of stress: cortisol and alpha-amylase", Psychoneuroendocrinology, 34, pp.1~ (2009)[DOI]
- Han QQ, "Inflammation: a mechanism of depression?", Neurosci Bull, 30, pp.515~523 (2014)[DOI]
- -(R)-PK11195 positron emission tomography study, "Brain Behav Immun", 2014, 219~225, 10.1016[DOI]